These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 32715103)

  • 1. HM1.24/BST-2 is constitutively poly-ubiquitinated at the N-terminal amino acid in the cytoplasmic domain.
    Fujimoto K; Nakashima S; Uchida S; Amen RNS; Ishii Y; Hirota Y; Tanaka Y
    Biochem Biophys Rep; 2020 Sep; 23():100784. PubMed ID: 32715103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif.
    Andrew AJ; Kao S; Strebel K
    J Biol Chem; 2011 Nov; 286(46):39967-81. PubMed ID: 21937450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.
    Fritz JV; Tibroni N; Keppler OT; Fackler OT
    Virology; 2012 Mar; 424(1):33-44. PubMed ID: 22222210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral Antagonism.
    Arias JF; Iwabu Y; Tokunaga K
    Front Microbiol; 2011; 2():250. PubMed ID: 22180752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
    Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
    J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.
    Fitzpatrick K; Skasko M; Deerinck TJ; Crum J; Ellisman MH; Guatelli J
    PLoS Pathog; 2010 Mar; 6(3):e1000701. PubMed ID: 20221443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vpu of a Simian Immunodeficiency Virus Isolated from Greater Spot-Nosed Monkey Antagonizes Human BST-2 via Two AxxxxxxxW Motifs.
    Yao W; Yoshida T; Hashimoto S; Takeuchi H; Strebel K; Yamaoka S
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology.
    Kupzig S; Korolchuk V; Rollason R; Sugden A; Wilde A; Banting G
    Traffic; 2003 Oct; 4(10):694-709. PubMed ID: 12956872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Vertebrate Evolution of the Host Restriction Factor Tetherin.
    Heusinger E; Kluge SF; Kirchhoff F; Sauter D
    J Virol; 2015 Dec; 89(23):12154-65. PubMed ID: 26401043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the endosomal ESCRT machinery in HIV-1 Vpu-induced down-regulation of BST2/tetherin.
    Janvier K; Roy N; Berlioz-Torrent C
    Curr HIV Res; 2012 Jun; 10(4):315-20. PubMed ID: 22524180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
    Neil SJ; Zang T; Bieniasz PD
    Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.
    Chen CY; Shingai M; Welbourn S; Martin MA; Borrego P; Taveira N; Strebel K
    J Virol; 2016 Dec; 90(24):11062-11074. PubMed ID: 27681141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counteraction of the multifunctional restriction factor tetherin.
    Sauter D
    Front Microbiol; 2014; 5():163. PubMed ID: 24782851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct internalization of cell-surface BST-2/tetherin by the HIV-1 accessory protein Vpu.
    Iwabu Y; Fujita H; Tanaka Y; Sata T; Tokunaga K
    Commun Integr Biol; 2010 Jul; 3(4):366-9. PubMed ID: 20798829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular logistics of BST-2/tetherin.
    Fujita H; Fujimoto K; Tokunaga K; Tanaka Y
    Curr HIV Res; 2012 Jun; 10(4):321-6. PubMed ID: 22533471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sites of action of HIV-1 Vpu in BST-2/tetherin downregulation.
    Arias JF; Iwabu Y; Tokunaga K
    Curr HIV Res; 2012 Jun; 10(4):283-91. PubMed ID: 22524176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human parainfluenza virus type 2 V protein inhibits and antagonizes tetherin.
    Ohta K; Goto H; Yumine N; Nishio M
    J Gen Virol; 2016 Mar; 97(3):561-570. PubMed ID: 26675672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BST-2 restricts IAV release and is countered by the viral M2 protein.
    Hu S; Yin L; Mei S; Li J; Xu F; Sun H; Liu X; Cen S; Liang C; Li A; Guo F
    Biochem J; 2017 Feb; 474(5):715-730. PubMed ID: 28087685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317.
    Bolduan S; Votteler J; Lodermeyer V; Greiner T; Koppensteiner H; Schindler M; Thiel G; Schubert U
    Virology; 2011 Jul; 416(1-2):75-85. PubMed ID: 21601230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.